Echo IQ Limited (ASX:EIQ)

Australia flag Australia · Delayed Price · Currency is AUD
0.620
-0.010 (-1.59%)
At close: Feb 27, 2026
113.79%
Market Cap 406.36M
Revenue (ttm) 218.37K
Net Income (ttm) -15.71M
Shares Out 655.41M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,534,357
Average Volume 2,303,074
Open 0.610
Previous Close 0.630
Day's Range 0.605 - 0.640
52-Week Range 0.165 - 0.640
Beta 0.67
RSI 74.55
Earnings Date Feb 25, 2026

About Echo IQ

Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia. [Read more]

Sector Healthcare
CEO Dustin Haines
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol EIQ
Full Company Profile

Financial Performance

In fiscal year 2025, Echo IQ's revenue was 101,409, an increase of 127.89% compared to the previous year's 44,500. Losses were -13.26 million, 145.2% more than in 2024.

Financial Statements

News

There is no news available yet.